Literature DB >> 26036761

MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.

Zhi-cai Shi1, Xue-rong Chu2, Yun-gang Wu1, Jin-hui Wu1, Chun-wen Lu1, Run-xiao Lü1, Mu-chen Ding1, Ning-fang Mao3.   

Abstract

Osteosarcoma has become one of the most common primary malignant bone tumors in childhood and adult. Numerous studies have demonstrated that aberrant microRNA (miRNA) expression is involved in human disease including cancer. To date, the potential miRNAs regulating osteosarcoma growth and progression are not fully identified yet. Herein, we showed that miR-375 was frequently downregulated in osteosarcoma tissue and cell lines compared to normal human colon tissues. Overexpression of miR-375 resulted in decreased expression of PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) at both mRNA and protein levels. We found that miR-375 overexpression markedly suppressed cell proliferation in vitro. And inhibition of miR-375 promotes osteosarcoma growth. Mechanistic studies showed that PIK3CA was a potential target of miR-375 and it mediated reduction of PIK3CA resulted in suppression of PI3K/Akt pathway. Taken together, our results demonstrate that miR-375 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA in osteosarcoma.

Entities:  

Keywords:  Cell proliferation; MicroRNA; Osteosarcoma; PIK3CA

Mesh:

Substances:

Year:  2015        PMID: 26036761     DOI: 10.1007/s13277-015-3614-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Cytotoxicity of voriconazole on cultured human corneal endothelial cells.

Authors:  Sang Beom Han; Young Joo Shin; Joon Young Hyon; Won Ryang Wee
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 2.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Authors:  Jinglei Miao; Song Wu; Zhi Peng; Mousumi Tania; Chaoyue Zhang
Journal:  Tumour Biol       Date:  2013-08

3.  Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.

Authors:  Chongwang Chang; Hangyu Shi; Chao Wang; Jing Wang; Ning Geng; Xue Jiang; Xuelian Wang
Journal:  Neurosci Lett       Date:  2012-10-26       Impact factor: 3.046

Review 4.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

5.  Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.

Authors:  Zhigang Wang; Haikang Cai; Lijun Lin; Mingjie Tang; Haiqing Cai
Journal:  Pediatr Blood Cancer       Date:  2013-09-09       Impact factor: 3.167

6.  Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma.

Authors:  Chien-Lin Wu; Hsiao-Chi Tsai; Zhen-Wei Chen; Chi-Ming Wu; Te-Mao Li; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Cell Signal       Date:  2013-09-12       Impact factor: 4.315

7.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma.

Authors:  Jie Luo; Jianhui Wu; Zenghong Li; Hao Qin; Bin Wang; Thian-Sze Wong; Weiqiang Yang; Qing-Ling Fu; Wenbin Lei
Journal:  Biomed Res Int       Date:  2014-08-12       Impact factor: 3.411

9.  miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.

Authors:  Yuanming Shen; Jiansong Zhou; Yang Li; Feng Ye; Xiaoyun Wan; Weiguo Lu; Xing Xie; Xiaodong Cheng
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

10.  A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells.

Authors:  Daya Luo; James M Wilson; Nikki Harvel; Jimei Liu; Lirong Pei; Shuang Huang; LesleyAnn Hawthorn; Huidong Shi
Journal:  J Transl Med       Date:  2013-03-05       Impact factor: 5.531

View more
  18 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Authors:  Qiongyan Zou; Wenjun Yi; Jianghai Huang; Fenfen Fu; Gannong Chen; Dewu Zhong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

3.  Modulation of mesenchymal stem cells with miR-375 to improve their therapeutic outcome during scar formation.

Authors:  Wei Sheng; Zihao Feng; Qi Song; Heyong Niu; Guoying Miao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

4.  Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.

Authors:  Yadong Wang; Shanfeng Zhang; Yan Xu; Yan Zhang; Hongya Guan; Xinjie Li; Yuebai Li; Yisheng Wang
Journal:  Tumour Biol       Date:  2016-09-28

5.  Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375.

Authors:  Gu Gong; Zhifeng Han; Wenjun Wang; Qinli Xu; Jingzhe Zhang
Journal:  Cell Cycle       Date:  2020-08-11       Impact factor: 4.534

6.  Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.

Authors:  Geoffroy Canlorbe; Zhe Wang; Enora Laas; Sofiane Bendifallah; Mathieu Castela; Marine Lefevre; Nathalie Chabbert-Buffet; Emile Daraï; Selim Aractingi; Céline Méhats; Marcos Ballester
Journal:  Mod Pathol       Date:  2016-02-05       Impact factor: 7.842

7.  Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis.

Authors:  Jian Xiao; Yong Zou; Xiaoxiao Lu; Bin Xie; Qiao Yu; Baimei He; Bixiu He; Qiong Chen
Journal:  Onco Targets Ther       Date:  2016-09-21       Impact factor: 4.147

8.  MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma.

Authors:  Zheng Zhou; Zhihong Li; Yi Shen; Tao Chen
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

9.  MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.

Authors:  Yang Qu; Su Pan; Mingyang Kang; Rongpeng Dong; Jianwu Zhao
Journal:  Tumour Biol       Date:  2015-11-11

10.  MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.

Authors:  Wei Liu; XiaoTao Zhao; Ying-Jian Zhang; Guang-Wen Fang; Yuan Xue
Journal:  J Int Med Res       Date:  2017-11-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.